Evidence map›Paper›PMID 16353923›Full record

ReviewThe AAPS journal2005

Neuropeptide-processing enzymes: applications for drug discovery.

Lloyd D Fricker

Open access · bronzeAbstract readReview
In one paragraph

Review in The AAPS journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Transcriptomics and Neuropeptidomics of the CockroachJournal of proteome research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Micropeptides translated from putative long non-coding RNAs.Acta biochimica et biophysica Sinica · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. A Caenorhabditis elegans Mass Spectrometric Resource for Neuropeptidomics.Journal of the American Society for Mass Spectrometry · 2018
    Article
  17. Neuropeptidomics of the Rat Habenular Nuclei.Journal of proteome research · 2018
    Article
  18. Review
  19. Neuropeptidergic integration of behavior inThe Journal of experimental biology · 2017
    Article
  20. Mining for Micropeptides.Trends in cell biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Lloyd D FrickerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. fricker@aecom.yu.edu
Albert Einstein College of Medicine · US

Funding

REGULATION OF ENKEPHALIN CONVERTASE--CARBOXYPEPTIDASE ER01DA004494 · NIDA · YESHIVA UNIVERSITY · PI FRICKER, LLOYD D · 1987 to 2015
$5.9M
STRUCTURE/FUNCTION OF CARBOXYPEPTIDASE DR01DK051271 · NIDDK · YESHIVA UNIVERSITY · PI FRICKER, LLOYD D · 1996 to 2008
$2.7M
Quantitative Peptidomics of Food DeprivationR21DK067350 · NIDDK · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI FRICKER, LLOYD D · 2004 to 2005
$334k
Peptidomics of Cocaine and Amphetamine AbuseR21DA017665 · NIDA · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI FRICKER, LLOYD D · 2004 to 2005
$167k
NIDA NIH HHS DA-04494NIDA NIH HHS DA-17665NIDDK NIH HHS DK-51271NIDDK NIH HHS DK-67350
6 · The paper itself

Abstract

Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.

Indexed as

AnimalsHumansNeuropeptidesPeptide HydrolasesTechnology, PharmaceuticalNeuropeptidesPeptide Hydrolases

Identifiers

PMID16353923
PMCPMC2750981
OpenAlexW2007463705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.